Intrinsic coagulation pathway: An activation threshold

Thrombosis Research

Volumn 99, Issue 3, 2000, Pages 285-293

  Pokhilko, Alexandra V ^a  

^a NATIONAL RESEARCH CENTER FOR HEMATOLOGY   (Russian Federation)

Author keywords

Activation threshold; Blood coagulation; Intrinsic pathway

Indexed keywords

BLOOD CLOTTING FACTOR 11A; CALCIUM;

ARTICLE; BLOOD CLOTTING TIME; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MAXIMUM ALLOWABLE CONCENTRATION; MODEL; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CALCIUM; DIATOMACEOUS EARTH; FACTOR XIA; HUMANS; HYDROLYSIS; MOTION; PLANT PROTEINS; PLASTICS; SURFACE PROPERTIES; TRYPSIN INHIBITOR, KUNITZ SOYBEAN;

EID: 0034209634     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00252-8     Document Type: Article

References (15)

1. Willems G.M., Lindhout T., Hermens W.T., Hemker H.C. Simulation model for thrombin generation in plasma. Haemost. 21:1991;197-207.
2. Zarnitsina V.I., Pokhilko A.V., Ataullakhanov F.I. A mathematical model for the spatio-temporal dynamics of intrinsic pathway of blood coagulation. I. The model description. Thromb Res. 84:1996;225-236.
3. Zarnitsina V.I., Pokhilko A.V., Ataullakhanov F.I. A mathematical model for the spatio-temporal dynamics of intrinsic pathway of blood coagulation. II. Results. Thromb Res. 84:1996;333-344.
4. Pokhilko A.V., Ataullakhanov F.I. Contact activation of blood coagulation. Trigger properties and hysteresis J Theor Biol. 191:1998;213-219.
5. Ataullakhanov F.I., Pokhilko A.V., Sinauridze E.I., Volkova R.I. Calcium threshold in human plasma clotting kinetics. Thromb Res. 75:1994;383-395.
6. Kozlov FF, Barkovskii FL, Bovenko VN, Pichugina NE. Patent of Russia N 1790604 of 09.22.92.
7. Tans G., Janssen-Claessen T., Rosing J., Griffin J.H. Studies on the effect of serine protease inhibitors on activated contact factors. Eur J Biochem. 164:1987;637-642.
8. Gallimore M.J. Chromogenic peptide substrate assays for determining components of the plasma kallikrein system. Scand J Clin Lab Invest. 45:1985;127-132.
9. Briseid K., Hoem N.O., Johannesen S., Haug K. Amidolytic assay of factor XI in human plasma-significance of kallikrein for the activity measured. Thromb Res. 78:1995;239-250.
10. Van Dieijen G., Tans G., Rosing J., Hemker H.C. The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem. 256:1981;3433-3441.
11. Rosing J., Tans G., Govers-Riemslag J.W.P., Zwaal R.F.A., Hemker H.C. The role of phospholipid and factor Va in the prothrombinase complex. J Biol Chem. 255:1980;274-283.
12. Colman R.W., Matter L., Sherry S. Studies on the prekallikrein-kallikrein enzyme system of human plasma. J Clin Invest. 48:1969;11-32.
13. Blezer R., Willems G.M., Cahalan P.T., Lindhout T. Initiation and propagation of blood coagulation at artificial surfaces in a capillary flow reactor. Thromb Haemost. 79:1998;296-301.
14. Wiggins R.C., Bouma B.N., Cochrane C.G., Griffin J.H. Role of high-molecular-weight ininogen in surface-binding and activation of coagulation factor XI and prekallikrein. Proc Natl Acad Sci USA. 74:1977;4636-4640.
15. Ataullakhanov F.I., Guria G.T., Sarbash V.I., Volkova R.I. Spatiotemporal dynamics of clotting and pattern formation in human blood. Biochem Biophys Acta. 1425:1998;453-468.